3 drug(s) with this reaction
316 total reports
Chest Discomfort has been reported as an adverse reaction across 3 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 316 adverse event reports mention chest discomfort in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with chest discomfort, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have chest discomfort listed in their FDA adverse event reports, sorted by report count:
In addition to chest discomfort, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
3 drug(s) manufactured by Chattem Inc have chest discomfort listed in their FDA adverse event reports: LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE.
There are a combined 316 reports of chest discomfort across 3 Chattem Inc drug(s) in the FDA adverse event database.